Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia - 07/08/11
Doi : 10.1016/j.jaci.2010.06.038
Hak-Ryul Kim, MD a, Chang-Duk Jun, PhD e, Young-Jin Lee, MD b, Sei-Hoon Yang, MD a, Eun-Taik Jeong, MD a, Seok-Don Park, MD c, Do-Sim Park, MD, PhD b, d 
a Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, Korea
b Department of Laboratory Medicine, School of Medicine, Wonkwang University, Iksan, Korea
c Department of Dermatology, School of Medicine, Wonkwang University, Iksan, Korea
d Institute of Wonkwang Medical Science, Wonkwang University, Iksan, Korea
e School of Life Sciences, Cell Dynamics Research Center, and Immune Synapse Research Center, GIST, Gwangju, Korea
| Supported by a grant from Wonkwang University in 2010 (to D.-S. P.). |
|
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 126 - N° 4
P. 880 - octobre 2010 Regresar al número
Artículo precedente
- The need for standardization in exercise challenge testing for exercise-induced asthma/bronchoconstriction
- Michael K. Stickland, Carol H. Spooner, Donna M. Dryden, Brian H. Rowe
- Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact?
- Collin R. Brooks, Robert Weinkove, Ian F. Hermans, Christine J. van Dalen, Jeroen Douwes
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?